Difference between revisions of "Cathepsin B (Bos taurus)"

From Cysteinome
Jump to: navigation, search
(Created page with "{| align="left" | __TOC__ |} {{#invoke:InfoboxforTarget|run|CTSB|[https://www.uniprot.org/uniprot/P07688 P07688]|Bos taurus|Cys108|[http://pfam.xfam.org/family/PF00112 Pep...")
 
(Experimental Evidence)
Line 40: Line 40:
  
 
==Experimental Evidence==
 
==Experimental Evidence==
:Crystallography, Nuclear Magnetic Resonance, Homologous Analysis of Sequence  
+
:Crystallography, Nuclear Magnetic Resonance, Homologous Analysis of Sequence
 
 
  
 
==Reference==
 
==Reference==

Revision as of 20:22, 27 July 2019

Lua error: data must be either of type string or number.

Summary

Protein Function

CSTB is a thiol protease which is believed to participate in intracellular degradation and turnover of proteins. It has also been implicated in tumor invasion and metastasis.
Hydrolysis of proteins with broad specificity for peptide bonds. Preferentially cleaves -Arg-Arg-|-Xaa bonds in small molecule substrates (thus differing from cathepsin L). In addition to being an endopeptidase, shows peptidyl-dipeptidase activity, liberating C-terminal dipeptides.

Cys Function & Property

$09

  • Hydrophobic property:
|600px
  • SASA:
Cys108: 4.137 A^2

Protein Sequence

MWRLLATLSC LLVLTSARSS LYFPPLSDEL VNFVNKQNTT WKAGHNFYNV
DLSYVKKLCG AILGGPKLPQ RDAFAADVVL PESFDAREQW PNCPTIKEIR
DQGSCGSCWA FGAVEAISDR ICIHSNGRVN VEVSAEDMLT CCGGECGDGC
NGGFPSGAWN FWTKKGLVSG GLYNSHVGCR PYSIPPCEHH VNGSRPPCTG
EGDTPKCSKT CEPGYSPSYK EDKHFGCSSY SVANNEKEIM AEIYKNGPVE
GAFSVYSDFL LYKSGVYQHV SGEIMGGHAI RILGWGVENG TPYWLVGNSW
NTDWGDNGFF KILRGQDHCG IESEIVAGMP CTHQY

Structural Information

  • Known structures with covalent ligands:
1QDQ, 1ITO, 1SP4, 2DC6
  • Protein structure

center|800px

Related Pathway

Experimental Evidence

Crystallography, Nuclear Magnetic Resonance, Homologous Analysis of Sequence

Reference

"# Yamamoto A, Tomoo K, Hara T, et al. Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex[J]. The Journal of Biochemistry, 2000, 127(4): 635-643 10739956

  1. Smith R A, Copp L J, Coles P J, et al. New inhibitors of cysteine proteinases. Peptidyl acyloxymethyl ketones and the quiescent nucleofuge strategy[J]. Journal of the American Chemical Society, 1988, 110(13): 4429-4431. DOI: 10.1021/ja00221a062
  2. Štern I, Schaschke N, Moroder L, et al. Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft[J]. Biochemical Journal, 2004, 381(2): 511-517.15084146
  3. Yamamoto A, Tomoo K, Matsugi K, et al. Structural basis for development of cathepsin B-specific noncovalent-type inhibitor: crystal structure of cathepsin B–E64c complex[J]. Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular Enzymology, 2002, 1597(2): 244-251. 12044902
  4. Watanabe D, Yamamoto A, Tomoo K, et al. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity–binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes[J]. Journal of molecular biology, 2006, 362(5): 979-993. 16950396
    "